Kryshtal Dmytro O, Gryshchenko Oleksiy, Gomez-Hurtado Nieves, Knollmann Bjorn C
Department of Medicine, Vanderbilt University, Nashville, TN, USA.
Department of Medicine, Vanderbilt University, Nashville, TN, USA; Department of General Physiology of Nervous System, Bogomoletz Institute of Physiology, Kyiv, Ukraine.
J Mol Cell Cardiol. 2015 May;82:75-83. doi: 10.1016/j.yjmcc.2015.02.027. Epub 2015 Mar 7.
In cardiac muscle, Ca(2+) release from sarcoplasmic reticulum (SR) is reduced with successively shorter coupling intervals of premature stimuli, a phenomenon known as SR Ca(2+) release refractoriness. We recently reported that the SR luminal Ca(2+) binding protein calsequestrin 2 (Casq2) contributes to release refractoriness in intact mouse hearts, but the underlying mechanisms remain unclear. Here, we further investigate the mechanisms responsible for physiological release refractoriness.
Gene-targeted ablation of Casq2 (Casq2 KO) abolished SR Ca(2+) release refractoriness in isolated mouse ventricular myocytes. Surprisingly, impaired Ca(2+)-dependent inactivation of L-type Ca(2+) current (ICa), which is responsible for triggering SR Ca(2+) release, significantly contributed to loss of Ca(2+) release refractoriness in Casq2 KO myocytes. Recovery from Ca(2+)-dependent inactivation of ICa was significantly accelerated in Casq2 KO compared to wild-type (WT) myocytes. In contrast, voltage-dependent inactivation measured by using Ba(2+) as charge carrier was not significantly different between WT and Casq2 KO myocytes. Ca(2+)-dependent inactivation of ICa was normalized by intracellular dialysis of excess apo-CaM (20 μM), which also partially restored physiological Ca(2+) release refractoriness in Casq2 KO myocytes.
Our findings reveal that the intra-SR protein Casq2 is largely responsible for the phenomenon of SR Ca(2+) release refractoriness in murine ventricular myocytes. We also report a novel mechanism of impaired Ca(2+)-CaM-dependent inactivation of Cav1.2, which contributes to the loss of SR Ca(2+) release refractoriness in the Casq2 KO mouse model and, therefore, may further increase risk for ventricular arrhythmia in vivo.
在心肌中,随着过早刺激的偶联间隔依次缩短,肌浆网(SR)的Ca(2+)释放减少,这种现象称为SR Ca(2+)释放不应期。我们最近报道,SR腔Ca(2+)结合蛋白肌集钙蛋白2(Casq2)有助于完整小鼠心脏中的释放不应期,但潜在机制仍不清楚。在此,我们进一步研究负责生理性释放不应期的机制。
基因靶向敲除Casq2(Casq2基因敲除)消除了分离的小鼠心室肌细胞中的SR Ca(2+)释放不应期。令人惊讶的是,负责触发SR Ca(2+)释放的L型Ca(2+)电流(ICa)的Ca(2+)依赖性失活受损,显著导致了Casq2基因敲除心肌细胞中Ca(2+)释放不应期的丧失。与野生型(WT)心肌细胞相比,Casq2基因敲除心肌细胞中ICa的Ca(2+)依赖性失活恢复明显加速。相反,使用Ba(2+)作为电荷载体测量的电压依赖性失活在WT和Casq2基因敲除心肌细胞之间没有显著差异。通过细胞内透析过量的脱辅基钙调蛋白(20μM)使ICa的Ca(2+)依赖性失活正常化,这也部分恢复了Casq2基因敲除心肌细胞中的生理性Ca(2+)释放不应期。
我们的研究结果表明,SR内蛋白Casq2在很大程度上负责小鼠心室肌细胞中SR Ca(2+)释放不应期现象。我们还报道了一种新的机制,即Cav1.2的Ca(2+)-钙调蛋白依赖性失活受损,这导致了Casq2基因敲除小鼠模型中SR Ca(2+)释放不应期的丧失,因此可能进一步增加体内室性心律失常的风险。